{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-20T12:23:43.592551+00:00",
  "news": [
    {
      "title": "Amgen's Imdelltra receives full FDA approval in small cell lung cancer - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNVWJKV3hISVpZTnBRXy1pSEdabkN5TnpHa0pCRjdfdEFNeFZRRlRuM2ZkYUxRdG5EY3JtT3lDb21GcHpUMGlLU2JjMHJVdGFRalhTZ0JmRE5oTWVhU2lvTnQxcG9hTTNIUkhYUS1YOTZaeW4zN3FrcFFnejBYaXp3WW40RG5SMU1nblUzb2ZYbklkOC1BelU0QkNiWjhQNjZiOExtUGs2Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNVWJKV3hISVpZTnBRXy1pSEdabkN5TnpHa0pCRjdfdEFNeFZRRlRuM2ZkYUxRdG5EY3JtT3lDb21GcHpUMGlLU2JjMHJVdGFRalhTZ0JmRE5oTWVhU2lvTnQxcG9hTTNIUkhYUS1YOTZaeW4zN3FrcFFnejBYaXp3WW40RG5SMU1nblUzb2ZYbklkOC1BelU0QkNiWjhQNjZiOExtUGs2Zw?oc=5\" target=\"_blank\">Amgen's Imdelltra receives full FDA approval in small cell lung cancer</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-19T22:29:33+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Here is what is being built in that pit by Highway 101 in Thousand Oaks - Ventura County Star",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNeGhSQ2FtQWZPdXp3QklmOGVkaTE2RW9rTjRXcFFZV3RkQU1WQjZfN2c1bE9xU1laaDljc0hoY1UzVnBqTFhmREJ0XzhMM28zOExsVXJaTFJybl9vTVU2UGY3eTFtWWJhSlVCQ2ttRFBZbWh4YVp1eE1zeUdZbmEzaWl6Mi0yNzhTdlVibmZtdDJhQkNydDF6VmxkS3hWQlVIQnVYYXNDQ01KOUdPZjZudmt6ZWVlQmc5?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNeGhSQ2FtQWZPdXp3QklmOGVkaTE2RW9rTjRXcFFZV3RkQU1WQjZfN2c1bE9xU1laaDljc0hoY1UzVnBqTFhmREJ0XzhMM28zOExsVXJaTFJybl9vTVU2UGY3eTFtWWJhSlVCQ2ttRFBZbWh4YVp1eE1zeUdZbmEzaWl6Mi0yNzhTdlVibmZtdDJhQkNydDF6VmxkS3hWQlVIQnVYYXNDQ01KOUdPZjZudmt6ZWVlQmc5?oc=5\" target=\"_blank\">Here is what is being built in that pit by Highway 101 in Thousand Oaks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Ventura County Star</font>",
      "published": "2025-11-17T13:40:14+00:00",
      "source": "Ventura County Star"
    },
    {
      "title": "CEO of drugmaker Amgen talks new results from cholesterol drug trial - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5\" target=\"_blank\">CEO of drugmaker Amgen talks new results from cholesterol drug trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-11-10T08:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5\" target=\"_blank\">Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump - The Wall Street Journal",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "The Wall Street Journal"
    },
    {
      "title": "Amgen cholesterol drug cuts risk of first cardiac event by 25% - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5\" target=\"_blank\">Amgen cholesterol drug cuts risk of first cardiac event by 25%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-11-08T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "The New York Times"
    },
    {
      "title": "Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5\" target=\"_blank\">Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-11-08T08:00:00+00:00",
      "source": "statnews.com"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - TradingView",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5\" target=\"_blank\">AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T13:36:48+00:00",
      "source": "TradingView"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-11-19",
      "close": 342.3999938964844
    },
    "history": [
      {
        "date": "2025-11-11",
        "close": 338.45001220703125
      },
      {
        "date": "2025-11-12",
        "close": 336.2799987792969
      },
      {
        "date": "2025-11-13",
        "close": 336.0
      },
      {
        "date": "2025-11-14",
        "close": 336.739990234375
      },
      {
        "date": "2025-11-17",
        "close": 341.7099914550781
      },
      {
        "date": "2025-11-18",
        "close": 343.989990234375
      },
      {
        "date": "2025-11-19",
        "close": 342.3999938964844
      }
    ],
    "name": "Amgen Inc."
  }
}